Gene therapy that alters hemoglobin genes may be an answer to curing sickle cell disease and beta thalassemia. Scientists at St. Jude Children’s Research Hospital and the Broad Institute of MIT and Harvard found base editing increased fetal hemoglobin production in a new treatment.
![](https://sciencenewsnet.in/wp-content/uploads/2023/07/649d91208e862_yen-natgen-00214345-010.jpeg.jpg)